Ele Ferrannini
Insights into SGLT2 Inhibitors: A Story of Discovery
Ele Ferrannini, M.D., is a professor of Internal Medicine at the University of Pisa and a senior research associate at the National Research Council Institute of Clinical Physiology.
He has published over 700 original papers on diabetes, metabolism and hypertension, as well as several reviews and textbook chapters.
His current research areas include insulin resistance and atherosclerosis, the pathophysiology of insulin secretion, the pathogenesis of insulin hypersecretion in obesity and the effects of weight loss, coronary atherosclerosis in diabetes, the pathogenesis of microvascular dysfunction and proteinuria in adult-onset diabetes.